Sponsor content
866 result(s) found, displaying 371 to 380
-
Australian public assessment report (AusPar)Bevacip/Bevaciptin (bevacizumab) for the treatment of types of cancer.
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXMED dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXEMCIP dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXMEDETOMIDINE CIPLA dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial.
-
CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial (318837)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial.